Bilateral retinal arteriolar occlusion secondary to OKT3 therapy.
Colleaux
K M
KM
Department of Ophthalmology, University of British Columbia, Vancouver, BC.
Ma
P E
PE
Purohit
S
S
D001157:Arterial Occlusive Diseases / Q000139:chemically induced* / Q000473:pathology; D001160:Arterioles / Q000187:drug effects / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects*; D012164:Retinal Diseases / Q000139:chemically induced* / Q000473:pathology; D012171:Retinal Vessels / Q000187:drug effects / Q000473:pathology
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3